What Changed
Price Move History
- Daily moves over 5%
- 27 252 sessions, October 30, 2025 to October 30, 2026
- Largest daily move
- +29.5% close of March 2, 2026
- 1-year change
- +14.8% closing prices, October 30, 2025 to October 30, 2026
- 1-month change
- +2.7% closing prices, September 30, 2026 to October 30, 2026
Company Description
Astrana Health, Inc. (NASDAQ: ASTH) is described as a physician-centric, AI-powered and technology-enabled healthcare company that supports providers in delivering high-quality, patient-centered care. According to the company’s public statements, Astrana is focused on making care more accessible, coordinated, and high-value by combining a scalable care delivery infrastructure, a proprietary technology platform, and aligned provider networks.
Astrana operates in the healthcare sector and is associated with the medical care facilities and population health management space. The company characterizes itself as patient-centered and physician-centric, with an emphasis on proactive, preventive care delivered at scale. Its model is built from the physician’s perspective, aiming to improve patient outcomes, enhance patient experiences, support provider well-being, and create greater value across the healthcare system.
Business model and segments
Based on available information, Astrana is an integrated population health management company. It focuses on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company reports three segments: Care Partners, Care Delivery, and Care Enablement. Astrana has stated that it generates the majority of its revenue from the Care Partners segment.
Through its affiliated provider networks, management services organization, and integrated care delivery clinics that span primary, specialty, and ancillary care, Astrana supports value-based care arrangements. Public disclosures note that Astrana supports more than 20,000 providers and over 1.6 million patients in value-based care arrangements. Earlier company descriptions referenced support for more than 12,000 providers and over one million patients, indicating that Astrana has expanded the scale of its operations over time.
Technology platform and AI focus
Astrana describes its platform as both technology-enabled and AI-powered. The company highlights a proprietary, end-to-end technology platform that is designed to empower providers to deliver more proactive and preventive care. Astrana associates this platform with real-time visibility into patients’ health, longitudinal patient relationships, and value-based care operations. In its public communications, Astrana links its use of automation and AI to operational efficiency and to supporting clinical and care management capabilities.
Value-based care and population health
The company emphasizes value-based care arrangements as a core part of its business. Astrana states that it supports providers and patients in value-based arrangements across multiple lines of business, including Medicare Advantage, Medicaid, and Commercial products, particularly through its networks and acquired businesses. Its population health management approach is described as coordinated and outcomes-based, with a focus on controlling medical cost trends while maintaining or improving quality and outcomes.
According to company materials, Astrana’s affiliated networks and clinics span primary care, specialty care, and ancillary services. Within this framework, Astrana’s Care Partners, Care Delivery, and Care Enablement segments relate to provider networks, care delivery sites, and enabling services and technology that support value-based care and delegated risk models.
Prospect Health acquisition and expanded footprint
On July 1, 2025, Astrana completed the acquisition of Prospect Health, a value-based integrated care delivery network. Prospect Health has been described as coordinating the delivery of high-quality care through a network of over 11,000 providers across Southern California, Texas, Arizona, and Rhode Island in its medical groups. Prospect Health serves approximately 600,000 members across Medicare Advantage, Medicaid, and Commercial lines of business and operates a California Restricted Knox-Keene-licensed health plan, a management services organization, a specialty pharmacy, and an acute care hospital.
Astrana has stated that the acquisition of Prospect Health is intended to deepen its capabilities in providing access to high-quality and high-value care and to expand its scale, capabilities, and physician reach across key markets. Subsequent company communications refer to combined operations with Prospect Health and integration efforts that are intended to expand Astrana’s care delivery platform.
Provider networks and care delivery infrastructure
Across its operations, Astrana reports that it supports providers through affiliated provider networks and a management services organization. The company also references integrated care delivery clinics that cover primary, specialty, and ancillary care. These elements form a care delivery infrastructure that Astrana associates with coordinated care, value-based arrangements, and delegated models where it manages aspects of medical cost and care quality.
In addition to its own networks and clinics, Astrana has highlighted partnerships with other health systems and provider groups. For example, the company has publicly announced a strategic partnership with Intermountain Health to expand access to coordinated care in southern Nevada by integrating Astrana’s provider network and clinics with Intermountain’s health system capabilities. Astrana has also disclosed partnerships with provider groups in Southern California within its Care Enablement business.
Financial reporting and growth orientation
Astrana is a public company that files reports with the U.S. Securities and Exchange Commission and trades on NASDAQ under the symbol ASTH. The company issues quarterly earnings releases and related Form 8-K filings that describe its financial results, segment performance, and guidance. In these communications, Astrana frequently references revenue and adjusted EBITDA, as well as medical cost trends and performance across its Care Partners, Care Delivery, and Care Enablement segments.
Company statements link its financial performance to the scale of its provider and patient base, the effectiveness of its value-based care model, and integration of acquired entities such as Collaborative Health Systems and Prospect Health. Astrana also notes the use of a term loan credit facility in connection with the Prospect Health acquisition and has discussed net leverage targets in its public disclosures.
Corporate communications and investor engagement
Astrana regularly participates in healthcare and investor conferences, including events hosted by J.P. Morgan, Wells Fargo, Morgan Stanley, Baird, and William Blair. The company uses these events, along with conference calls and webcasts, to discuss its financial results, strategy, and operations. Astrana also furnishes investor presentations via Form 8-K and maintains an investor relations calendar where it posts webcast links and presentation materials.
Stock Performance
Astrana Health (ASTH) closed at $36.53 on October 30, 2026. Over the past 12 months, the price has gained 14.8%.
ASTH Metrics & Rankings
Price returns through October 30, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Astrana Health has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 1 with negative movement. Key topics include partnership, conferences, earnings date, earnings, management. View all ASTH news →
SEC Filings
Astrana Health has filed 10 recent SEC filings, including 6 Form 4, 3 Form 8-K, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ASTH SEC filings →
Financial Highlights
Astrana Health generated $3.2B in revenue in FY2025, retaining a 10.7% gross margin, operating income reached $78.5M (2.5% operating margin), and net income was $22.5M, reflecting a 0.7% net profit margin. Diluted earnings per share stood at $0.46. The company generated $114.6M in operating cash flow. The current ratio was 1.40, measuring current assets divided by current liabilities.
Upcoming Events
Q3 2026 results
Earnings conference call
Astrana Health has 2 upcoming scheduled events. The next event, "Q3 2026 results", is scheduled for November 5, 2026 (in 3 days). All of them are earnings releases or calls. Investors can track these dates to stay informed about potential catalysts that may affect the ASTH stock price.
Short Interest History
Short interest in Astrana Health (ASTH) currently stands at 3.0 million shares, down 2.5% from the previous reporting period, representing 6.8% of the float. Since November 2025, short interest has increased by 26.3%.
Days to Cover History
Days to cover for Astrana Health (ASTH) currently stands at 8.8 days, up 52.6% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 173.1%. Across the settlements charted above, it has ranged from 3.1 to 11.7 days.
ASTH Company Profile & Sector Positioning
Astrana Health (ASTH) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing ASTH often look at related companies in the same sector, including AMN Healthcare Services (AMN), Sonida Senior Living, Inc. (SNDA), Ardent Health, Inc. (ARDT), Healthcare Services Group (HCSG), and The Pennant Group, Inc. (PNTG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ASTH's relative position within its industry.